To κ+ B or not to κ+ B
Crossref DOI link: https://doi.org/10.1038/ni.3277
Published Online: 2015-09-18
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fisher, Megan R
Bassing, Craig H
Text and Data Mining valid from 2015-09-18
Article History
First Online: 18 September 2015
Competing interests
: C.H.B. is a consultant for Regeneron Pharmaceuticals.